PI
BSTC

Putnam Investments’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Putnam Investments’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-29,485
Closed -$1.62M – 1358
2017
Q1 		$1.62M Sell
29,485
-3,457
-10% -$183K ﹤0.01% 904
2016
Q4 		$1.83M Sell
32,942
-294
-0.9% -$14.1K ﹤0.01% 859
2016
Q3 		$1.52M Sell
33,236
-21,214
-39% -$852K ﹤0.01% 922
2016
Q2 		$2.17M Buy
54,450
+18,730
+52% +$686K 0.01% 906
2016
Q1 		$1.24M Buy
35,720
+729
+2% +$26.8K ﹤0.01% 1063
2015
Q4 		$1.5M Sell
34,991
-831
-2% -$41.6K ﹤0.01% 1046
2015
Q3 		$1.56M Buy
35,822
+1,040
+3% +$56.1K ﹤0.01% 1057
2015
Q2 		$1.79M Sell
34,782
-279
-0.8% -$11.9K ﹤0.01% 1094
2015
Q1 		$1.37M Sell
35,061
-1,432
-4% -$56.1K ﹤0.01% 1145
2014
Q4 		$1.41M Sell
36,493
-204
-0.6% -$7.78K ﹤0.01% 1127
2014
Q3 		$1.3M Buy
36,697
+597
+2% +$17.5K ﹤0.01% 1153
2014
Q2 		$973K Buy
36,100
+45
+0.1% +$1.17K ﹤0.01% 1195
2014
Q1 		$935K Sell
36,055
-198,617
-85% -$4.76M ﹤0.01% 1216
2013
Q4 		$5.09M Sell
234,672
-61,989
-21% -$1.27M 0.01% 741
2013
Q3 		$5.78M Buy
296,661
+25,778
+10% +$457K 0.02% 636
2013
Q2 		$4.23M Buy
+270,883
New +$4.36M 0.01% 772

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return

Putnam Investments's BSTC Position: Q2 2017 in Review

Putnam Investments sold out of BioSpecifics Technologies Corp. (BSTC) in Q2 2017, closing a stake of 29,485 shares — an estimated $1.62M sold.

Putnam Investments first reported a position in BSTC in Q2 2013 and held it in 16 quarters. The position peaked at $5.78M in Q3 2013. 90 funds tracked by Wall St. Rank hold BSTC as of Q2 2017.

  • Putnam Investments reported no remaining BioSpecifics Technologies Corp. position as of Q2 2017 after selling out during the quarter.
  • Putnam Investments sold 29,485 BioSpecifics Technologies Corp. shares in Q2 2017, an estimated $1.62M.
  • Putnam Investments first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 16 quarters.
  • Putnam Investments's BioSpecifics Technologies Corp. position peaked at $5.78M in Q3 2013.
  • 90 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q2 2017.

Based on Putnam Investments's 13F filing for Q2 2017, filed 14 Aug 2017.